GENERAL

Clinical Trials Show Relapsing Multiple Sclerosis Patients Benefit From Mavenclad®, a New Drug by Merck

 |  Friday, 07 May 2021 11:01  |  Published in GENERAL

Petaling Jaya, 3 May 2021 – Merck Sdn Bhd has launched MAVENCLAD® (cladribine), a short-course oral therapy now approved in Malaysia for the treatment of adult patients with relapsing forms of multiple sclerosis. Clinical data indicates that  MAVENCLAD® has four years of efficacy with a maximum of 20 days oral treatment over two years1-4.

Multiple sclerosis (MS) is an immune mediated disorder and chronic disease of the central nervous system which damages the brain’s ability to perform fundamental functions.  It is a rare disease affecting 2.8 million people worldwide as at 20205. Multiple sclerosis has an estimated prevalence  of two to three per 100,000 population in Malaysia.While it is an uncommon disease, there is clearly an unmet need to improve the diagnosis, treatment and management for adult patients with relapsing multiple sclerosis, seeing how the disease impacts patients at the prime of their lives. 

Red Hat Helps Drive Telecommunications Modernization Across the Globe with Open Hybrid Cloud Technologies

 |  Friday, 07 May 2021 10:59  |  Published in GENERAL

KUALA LUMPUR, 3 MAY 2021 – Red Hat, Inc., the world's leading provider of open source solutions, today announced that several communications service providers (CSPs) across the globe have chosen Red Hat to help them modernize networks in order to better meet the challenges of an incredibly competitive, evolving and growing marketplace. With the emergence of 5G, CSPs are now tasked with providing modern networks that connect organizations in every industry, from healthcare to smart cars and more. 

Red Hat’s open hybrid cloud technologies provide the foundation and capabilities that many service providers require to virtualize and containerize their networks, enabling the faster delivery of new and innovative applications and services. These implementations include:

Accelerate Your Digital Transformation with the New Canon imageRUNNER ADVANCE (iR-ADV) DX C5800i Series

 |  Friday, 07 May 2021 10:57  |  Published in GENERAL

SHAH ALAM, 4 May 2021 – Canon Marketing Malaysia (“Canon”) announces the launch of their new imageRUNNER ADVANCE (iR-ADV) DX C5800i series today, a state-of-the-art range of A3 colour laser multi-function devices (MFDs) that is specially designed to help businesses looking to accelerate digital transformation (DX). As the workplace is becoming more fluid, and hybrid working is a new reality, this latest offering helps companies to effectively drive their DX to the next level.  With robust security and flexible cloud connectivity, the new iR-ADV DX C5800i series enables unrivalled productivity in office and remote locations.


Page 899 of 1268